SHERIDAN, WYOMING – May 8, 2025 – Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in serving science, has announced that Marc N. Casper, the company’s chairman, president, and chief executive officer, will be presenting at the highly anticipated BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 11:40 a.m. (ET). The presentation will be available via a live webcast, accessible through the Investors section of Thermo Fisher’s official website.
Key Insights on Thermo Fisher’s Presentation
The BofA Securities Health Care Conference is a prominent event in the health care industry, bringing together leading figures from across the sector. Marc N. Casper’s participation underscores Thermo Fisher’s strategic position in advancing the life sciences sector and its role in driving innovation. As the company continues to make significant strides in scientific research, diagnostics, and the development of life-changing therapies, this event offers a valuable platform for Thermo Fisher to engage with investors and industry stakeholders.
During the presentation, Casper is expected to discuss Thermo Fisher’s ongoing initiatives to accelerate life sciences research, enhance laboratory productivity, and improve patient health outcomes globally. The company’s mission to enable its customers to make the world healthier, cleaner, and safer remains central to its operational strategy.
Strategic Role in Advancing Global Health
Thermo Fisher Scientific continues to lead the way in providing innovative solutions to critical challenges in health and science. The company’s comprehensive portfolio includes cutting-edge technologies and services, supporting researchers, clinicians, and pharmaceutical companies worldwide. By integrating advanced technologies with a robust service model, Thermo Fisher helps to enhance productivity and drive operational improvements across the life sciences and health care sectors.
Key areas of focus include:
- Life Sciences Research: Thermo Fisher provides critical tools and support for advancing scientific research in areas such as genomics, proteomics, and cellular biology.
- Diagnostics: The company continues to play a pivotal role in improving diagnostic capabilities, with solutions that help clinicians deliver faster and more accurate patient outcomes.
- Pharmaceutical Services: Thermo Fisher’s services are essential for the development and manufacture of life-saving therapies, ensuring the efficient and reliable production of new drugs.
These efforts directly contribute to Thermo Fisher’s broader mission, with a focus on sustainability and enhancing global health outcomes.
Thermo Fisher’s Global Impact
Thermo Fisher Scientific’s global reach and influence in the science and health care sectors are reflected in its annual revenue of over $40 billion. The company operates through several industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Through these brands, Thermo Fisher delivers an unmatched combination of innovative technologies, product convenience, and unparalleled pharmaceutical services.
By leveraging its global infrastructure, Thermo Fisher continues to empower its customers to achieve groundbreaking discoveries and improve health and safety standards worldwide. As the world faces increasingly complex challenges in science and health care, Thermo Fisher remains committed to supporting its customers and advancing the science that leads to better health outcomes.
Learn More
For more information on Thermo Fisher’s offerings and to watch the live webcast of Marc N. Casper’s presentation at the BofA Securities Health Care Conference, visit www.thermofisher.com.